Hospital readmissions after elective lower extremity vascular procedures

Author:

Vogel Todd R1,Smith Jamie B2,Kruse Robin L2

Affiliation:

1. Division of Vascular Surgery, University of Missouri, School of Medicine, Columbia, USA

2. Department of Family and Community Medicine, University of Missouri, School of Medicine, Columbia, USA

Abstract

Background This study evaluated risk factors associated with 30-day readmission after open and endovascular lower extremity revascularization. Methods Patients admitted with peripheral artery disease and lower extremity procedures were selected from national electronic medical record data, Cerner Health Facts® (2008–2014). Thirty-day readmission was determined. Logistic regression models identified characteristics independently associated with readmission. Results There were 2781 open and 2611 endovascular procedures. Readmission was 10.9% (9.6% open versus 12.3% endovascular, p<.0001). Greater disease severity was associated with readmission for both groups. Readmission factors for lower extremity bypass: blood transfusions (OR 2.25, 95% CI 1.62–3.13), hyponatremia (OR 1.72, 95% CI 1.15–2.57), heart failure (OR 1.57, 95% CI 1.07–2.29), bronchodilators (OR 1.50, 95% CI 1.13–2.00), black race (OR 1.43, 95% CI 1.03–1.99), and hypokalemia (OR 0.43, 95% CI 0.20–0.95). Readmission factors for endovascular procedures: vasodilators (OR 1.63, 95% CI 1.22–2.16), end-stage renal disease (OR 1.43, 95% CI 1.02–2.01), fluid and electrolyte disorders (OR 1.44, 95% CI 1.00–2.06), hypertension (OR 1.33, 95% CI 0.99–1.76), coronary artery disease (OR 1.31, 95% CI 1.02–1.67), and diuretics (OR 1.30, 95% CI 1.01–1.70). Conclusions Readmission after lower extremity revascularization is associated with disease severity for both procedures. Factors associated with readmission following lower extremity bypass included heart failure, transfusions, hyponatremia, black race, and bronchodilator use. Risk factors for endovascular readmissions were often chronic conditions including coronary artery disease, kidney disease, hypertension, and hypertensive medications. Awareness of risk factors may help providers identify high-risk patients who may benefit from increased surveillance and programs to lower readmission.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine,Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3